Jacob S. Sherkow (@[email protected])
@jsherkow
Followers
5K
Following
3K
Media
720
Statuses
14K
Prof @UIllinoisLaw, @IllinoisMed, @IGBIllinois, @eucenter; also @CeBIL_Center #patents, #IP, #biotech, #pharma, #bioethics. Ducks, drugs, and nicks that roll.
Champaign, IL
Joined August 2012
1/ OK, everyone, buckle up. @RESachs and I have a piece @TheAtlantic about Aduhelm. It's about how the law links FDA approval to payment policy, which means we're likely to spend through the nose for a drug that may not work. https://t.co/rGfD67IQn6
13
157
330
The FDA's approval of Aduhelm is a big fucking deal, and not in a good way, as @RESachs explains here:
healthaffairs.org
It is rare for an FDA approval decision to have the potential to fundamentally reshape many different aspects of health care policy, but the agency’s decision to approve Aduhelm so broadly could do...
0
14
44
Everything you need to know about when you could get a Covid-19 vaccine and how, by @Loftus and @betswrites
wsj.com
This is what we know and don’t know about how, and when, the coronavirus vaccine is likely to reach Americans, from high-risk people and essential workers to those in the general population.
0
2
4
.@PennMedicine scientist Drew Weissman talked to @CNN's @drsanjaygupta about how the mRNA tech he developed at Penn will help save the world from #COVID19 and revolutionize medicine
1
6
10
Not my area but a really interesting online symposium:
Check out @UChiLRev's online symposium on COVID-19 and Criminal Justice featuring essays by Professors @SharonDolovich, @valenabeety, @ProfPamMetzger and @jenndoliva! https://t.co/OLb2HeKPCj
#WomenAlsoKnowLaw
0
0
1
Perspectives on Biohackers and DIY CRISPR
ipscell.com
How should we view biohackers and their DIY use of CRISPR outside of the traditional industry or academic lab environment?
1
3
5
Always read @RESachs on drug pricing proposals. https://t.co/c7X9p8LXw4
0
4
5
As we approach Thanksgiving, just wanted to give thanks to everyone at @HarvardEthics for the incredible year last year. Miss you all! Hope we can see each other again, soon.
1
0
4
A third Covid-19 vaccine, this one developed by AstraZeneca and the University of Oxford, was found to be effective. @jennystrasburg reports this candidate was as much as 90% effective depending on the dosing.
wsj.com
The success of the vaccine being developed by the University of Oxford and AstraZeneca bodes well for the near-term availability of a third treatment for Covid-19, joining those from Moderna as well...
2
6
14
We have scheduled a meeting of our Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10th to discuss an emergency use authorization request for a #COVID19 vaccine. https://t.co/VtOWCPEZdP
53
87
155
If this external VRBPAC review of the 1st vaccine goes well, we'll likely see Phase 1a distribution begin right after December 10th https://t.co/wTeGhh9mD6
https://t.co/BQX2ABNdN3
19
140
488
In the spring, everyone said it would take 12 to 18 months for a vaccine. Here’s the improbable tale of how Moderna, Pfizer, BioNTech and a massive federal effort drastically shortened that timeline.
nytimes.com
The furious race to develop a coronavirus vaccine played out against a presidential election, between a pharmaceutical giant and a biotech upstart, with the stakes as high as they could get.
6
41
102
Covid-19 antibody drug from Regeneron is authorized by @US_FDA, the second such antibody drug to gain clearance. Story coming to @WSJ...
fda.gov
The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
1
11
14
🦆 ALL HAIL LONG BOI 🦆 The final results: Long Boi - 2,182 Lancaster Ducks - 2,090 SWANsea Swans - 1,048 Cath the OU Duck - 774 See the full table at https://t.co/WahPdOcNgq
9
69
469
How should #innovation policymakers think about #AI—and its biases—in addressing #COVID? A new WD Post from @WNicholsonPrice, @RESachs, me & @PatentScholar
0
4
3
Check out this excellent tweet thread on public funding of drug innovation!
Happy to see the @USGAO cite our investigation, Revisiting the National Institutes of Health Fair Pricing Condition in @AnnalsofIM
https://t.co/51AEiFTKzT. 1/5
0
4
6
WOOOOOOOT!
The drug maker Pfizer and its German partner BioNTech said Friday afternoon they have applied to the FDA for an emergency use authorization for their Covid-19 vaccine. https://t.co/Ru97Q8xAiY
#Pfizer #BioNTech #COVID19 #vaccine
0
0
2